Shaolin Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-75,033
Closed -$33K – 800
2022
Q3
$33K Sell
75,033
-74,225
-50% -$43.8K ﹤0.01% 638
2022
Q2
$72K Sell
149,258
-75,742
-34% -$42.2K ﹤0.01% 630
2022
Q1
$137K Buy
+225,000
New +$123K ﹤0.01% 616

Other funds holding DRTSW

Shaolin Capital Management's DRTSW Position: Q4 2022 in Review

Shaolin Capital Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2022, closing a stake of 75,033 shares — an estimated $33K sold.

Shaolin Capital Management first reported a position in DRTSW in Q1 2022 and held it in 3 quarters. The position peaked at $137K in Q1 2022. 34 funds tracked by Wall St. Rank hold DRTSW as of Q4 2022.

  • Shaolin Capital Management reported no remaining Alpha Tau Medical Warrant position as of Q4 2022 after selling out during the quarter.
  • Shaolin Capital Management sold 75,033 Alpha Tau Medical Warrant shares in Q4 2022, an estimated $33K.
  • Shaolin Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 3 quarters.
  • Shaolin Capital Management's Alpha Tau Medical Warrant position peaked at $137K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2022.

Based on Shaolin Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.